Idera Pharmaceuticals Inc Financial and Strategic SWOT Analysis Review [Report Updated: 05072017] Prices from USD $125

20:17 EDT 19 Aug 2017 | BioPortfolio Reports

Idera Pharmaceuticals Inc Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Idera Pharmaceuticals Inc Idera is a clinical stage biotechnology company which focuses on the discovery, development and commercialization of drug candidates for the treatment of life threatening diseases. It develops DNA and RNA based drug candidates that are targeted against tolllike receptors TLR for the treatment of infectious diseases and which can be used as vaccine adjuvants. The company initiated a research program employing its gene silencing technologies to inhibit the production of diseaseassociated proteins by targeting RNA. The company designs and formulates proprietary TLR agonists and antagonists to modulate immune responses. The lead product in the pipeline is IMO2125, IMO8400, IMO9200, and antagonist of TLRs 7, 8, and 9 for the treatment of lupus. Idera is headquartered in Massachusetts, the US.

Idera Pharmaceuticals Inc Key Recent Developments

May 04,2017: Idera Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update
Apr 18,2017: Idera Pharmaceuticals Announces Organizational Update
Mar 15,2017: Idera Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Provides Corporate Update
Oct 28,2016: Idera Pharmaceuticals Reports Third Quarter 2016 Financial Results
Aug 24,2016: Idera Pharmaceuticals Presents the Novel Mechanism of Action of its Third Generation Antisense Technology

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Idera Pharmaceuticals Inc Financial and Strategic SWOT Analysis Review [Report Updated: 05072017] Prices from USD $125


More From BioPortfolio on "Idera Pharmaceuticals Inc Financial and Strategic SWOT Analysis Review [Report Updated: 05072017] Prices from USD $125"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...